TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that…
View More FDA Approves Inmazeb (atoltivimab, maftivimab and odesivimab-ebgn) Antibody Cocktail for Ebola (Zaire Ebolavirus)
Home »
White House approves tougher rules for COVID-19 vaccine development
(HealthDay)—Following weeks of delay, the White House on Tuesday approved tough new rules for COVID-19…
View More White House approves tougher rules for COVID-19 vaccine development
White House Approves Tougher Rules for COVID-19 Vaccine Development
WEDNESDAY, Oct. 7, 2020 — Following weeks of delay, the White House on Tuesday approved…
View More White House Approves Tougher Rules for COVID-19 Vaccine Development
FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
PRINCETON, N.J.–(BUSINESS WIRE) October 2, 2020 — Bristol Myers Squibb (NYSE: BMY) today announced that…
View More FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) as the First and Only Immunotherapy Treatment for Previously Untreated Unresectable Malignant Pleural Mesothelioma
FDA approves first contact lens that slows myopia progression
(HealthDay)—MiSight, the first contact lens indicated to slow the progression of myopia in children ages…
View More FDA approves first contact lens that slows myopia progression
FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
SAN DIEGO, Feb. 26, 2019 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology…
View More FDA Approves Supplemental New Drug Application to Expand Cinvanti (aprepitant) Label for IV Push
FDA approves mavyret for children, adolescents with hep C
(HealthDay)—Mavyret (glecaprevir and pibrentasvir) tablets are now approved to treat all six genotypes of hepatitis…
View More FDA approves mavyret for children, adolescents with hep C
FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
April 4, 2019 — Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration…
View More FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ — The U.S. Food and Drug Administration has approved…
View More FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
FDA Approves Vaxelis
BRIDGEWATER, N.J. and KENILWORTH, N.J. – December 26, 2018 –The U.S. Food and Drug Administration…
View More FDA Approves Vaxelis